Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Takeda

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2022
Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with EmphysemaYuji Yamamoto, Haruhiko Hirata, Takayuki Shiroyama, et al.
American Journal of Respiratory and Critical Care Medicine|January 18, 2011
Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapyKaori Nakanishi, Yoshito Takeda, Satoshi Tetsumoto, et al.
Inflammation|April 10, 2004
Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosisSeiji Hayashi, Kin'ya Abe, Hiroto Matsuoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patientsJonas Nørskov Søndergaard, Janyerkye Tulyeu, Ryuya Edahiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2011
Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lungRyo Takahashi, Haruhiko Hirata, Isao Tachibana, et al.
Anticancer Research|December 31, 2021
Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective AnalysisKazuhiko Hayashi, Osamu Suzuki, Hiroya Shiomi, et al.
Ebiomedicine|January 23, 2025
Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugatesYuichi Adachi, Kotaro Miyake, Kika Ohira, et al.
DNA and Cell Biology|April 10, 2007
Gefitinib-sensitive EGFR lacking residues 746-750 exhibits hypophosphorylation at tyrosine residue 1045, hypoubiquitination, and impaired endocytosisMitsugi Furukawa, Izumi Nagatomo, Toru Kumagai, et al.
The Journal of Cell Biology|June 11, 2003
Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytesYoshito Takeda, Isao Tachibana, Kenji Miyado, et al.
Thoracic Cancer|October 26, 2020
Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature reviewTakayuki Niitsu, Takayuki Shiroyama, Kotaro Miyake, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2022
Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with EmphysemaYuji Yamamoto, Haruhiko Hirata, Takayuki Shiroyama, et al.
American Journal of Respiratory and Critical Care Medicine|January 18, 2011
Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapyKaori Nakanishi, Yoshito Takeda, Satoshi Tetsumoto, et al.
Inflammation|April 10, 2004
Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosisSeiji Hayashi, Kin'ya Abe, Hiroto Matsuoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patientsJonas Nørskov Søndergaard, Janyerkye Tulyeu, Ryuya Edahiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2011
Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lungRyo Takahashi, Haruhiko Hirata, Isao Tachibana, et al.
Anticancer Research|December 31, 2021
Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective AnalysisKazuhiko Hayashi, Osamu Suzuki, Hiroya Shiomi, et al.
Ebiomedicine|January 23, 2025
Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugatesYuichi Adachi, Kotaro Miyake, Kika Ohira, et al.
DNA and Cell Biology|April 10, 2007
Gefitinib-sensitive EGFR lacking residues 746-750 exhibits hypophosphorylation at tyrosine residue 1045, hypoubiquitination, and impaired endocytosisMitsugi Furukawa, Izumi Nagatomo, Toru Kumagai, et al.
The Journal of Cell Biology|June 11, 2003
Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytesYoshito Takeda, Isao Tachibana, Kenji Miyado, et al.
Thoracic Cancer|October 26, 2020
Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature reviewTakayuki Niitsu, Takayuki Shiroyama, Kotaro Miyake, et al.
Pageof 15